ACARIX strengthens US Commercial Team
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ...
Invitation to presentation of Acarix´s fourth quarter report
Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C...
Acarix is attending 2023 BIO CEO & Investor Conference in New York City
Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ...
Acarix announces last day of trading with BTU and first day of trading in warrants
THIS ANNOUNCEMENT IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, C...
Acarix carries out a directed issue of shares to guarantors in connection with the completed rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Acarix announces final outcome of rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Acarix publish supplement to prospectus
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
The guarantee consortium is expanded to cover approximately 62% of the ongoing rights issue in Acarix
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Acarix secures insurance coverage in Texas and receives first CADScor®System order
Acarix, a leader in acoustic and AI-based cardiac diagnostics, confirms insurance coverage for the CADScor®System by key payors in ...
Acarix receives additional orders of CADScor®System in Louisiana, USA
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today that the company has received additional orders for the ...
Acarix publishes prospectus in connection with the company’s rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Announcement from Acarix’s extra general meeting
The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 9 December 2022 and the following resolutions were...